Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Rosetta Genomics Ltd (ROSG)

RSI still at 66.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Penny Gold Mine Member Profile
Member Level 
Followed By 163
Posts 5,489
Boards Moderated 3
Alias Born 12/14/09
160x600 placeholder
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/17/2014 4:28:56 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/16/2014 4:05:10 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/8/2014 7:57:47 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/8/2014 7:55:18 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/2/2014 4:30:39 PM
Rosetta Genomics Receives Notice of Allowance for U.S. Patent for the Prognosis and Treatment of Prostate Cancer "Marketwired" - 6/26/2014 9:43:56 AM
Rosetta Genomics & Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer Diagnos... "Marketwired" - 6/9/2014 8:10:00 AM
Rosetta Genomics and Moffitt Cancer Center Enter Into Agreement to Advance Development of microRNA-Based Cancer Diagnostic "Marketwired" - 6/9/2014 7:02:00 AM
Rosetta Genomics to Receive U.S. Patent for Cancer Origin Assay "Marketwired" - 4/4/2014 8:15:00 AM
Rosetta Genomics & Marina Biotech Establish Strategic Alliance to Jointly Develop microRNA-Based Diagnostics & Therapeutics f... "Marketwired" - 4/2/2014 9:08:29 AM
Rosetta Genomics Reports 2013 Financial Results "Marketwired" - 3/31/2014 6:05:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/31/2014 4:16:45 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 3/31/2014 4:12:54 PM
Annual and Transition Report (foreign Private Issuer) (20-f) "Edgar (US Regulatory)" - 3/31/2014 4:10:11 PM
Rosetta Genomics to Host Business Update Conference Call on April 1, 2014 "Marketwired" - 3/25/2014 2:50:00 PM
Rosetta Genomics Enters Collaboration With Clalit Health Services' Rabin Medical Center for microRNA-Based Assay for Chronic ... "Marketwired" - 3/24/2014 9:15:00 AM
Rosetta Genomics' Cancer Origin Test Highlighted at Landmark CUP Foundation Seminar 2014 "Marketwired" - 3/21/2014 12:15:00 PM
Approvals, Clinical Trial Results, Stock Summaries, Data Publication and Conference Participation - Analyst Notes on Northwes... "PR Newswire (US)" - 3/13/2014 8:20:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/12/2014 10:12:41 AM
Rosetta Genomics Provides Product Pipeline Update "Marketwired" - 3/12/2014 8:15:00 AM
Rosetta Genomics Announces Publication of Data Correlating miR-150 to Atrial Fibrillation in Patients With Chronic Systolic H... "Marketwired" - 3/3/2014 9:15:00 AM
Rosetta Genomics to Receive Important U.S. Patent for Oncology Therapeutic "Marketwired" - 2/26/2014 8:45:00 AM
Rosetta Genomics Executes Agreement With MultiPlan "Marketwired" - 2/18/2014 8:45:00 AM
Rosetta Genomics Appoints Kevin Watson as Director, Reimbursement-Managed Care "Marketwired" - 2/18/2014 8:25:00 AM
Rosetta Cancer Origin Test Now Covered by Highmark Health Services, the Fourth Largest U.S. Blue Cross & Blue Shield-Affiliat... "Marketwired" - 1/21/2014 8:30:00 AM
Penny Gold Mine Member Level  Thursday, 05/31/12 08:32:15 AM
Re: None
Post # of 1791 
RSI still at 66.

needs to cool off still for next run.IMO

11 may be enough

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist